Utility of shape evolution and displacement in the classification of chronic multiple sclerosis lesions

DT Okuda, TM Moog, M McCreary, JN Bachand… - Scientific reports, 2020 - nature.com
The accurate recognition of multiple sclerosis (MS) lesions is challenged by the high
sensitivity and imperfect specificity of MRI. To examine whether longitudinal changes in …

Cerebral blood perfusion changes in multiple sclerosis

J Wuerfel, F Paul, F Zipp - Journal of the neurological sciences, 2007 - Elsevier
The proximity of immune cell aggregations to the vasculature is a hallmark of multiple
sclerosis. Furthermore, it is widely accepted that inflammation is able to modulate the …

Interferon-β in the treatment of relapsing–remitting multiple sclerosis

M Revel - Pharmacology & therapeutics, 2003 - Elsevier
The role of interferon-β as a disease-modifying drug (DMD) for the treatment of relapsing–
remitting multiple sclerosis (RRMS) is now well established, and its efficacy has been …

Interferon-β-1b slows progression of atrophy in RRMS: three-year follow-up in NAb− and NAb+ patients

JA Frank, N Richert, C Bash, L Stone, PA Calabresi… - Neurology, 2004 - AAN Enterprises
Objective: To determine the effect of interferon-β-1b (IFNβ-1b) treatment on total contrast-
enhancing lesions (CEL), white matter lesion load (WMLL), and cerebral atrophy (CA) in …

Study of relapsing remitting experimental allergic encephalomyelitis SJL mouse model using MION‐46L enhanced in vivo MRI: early histopathological correlation

S Xu, EK Jordan, S Brocke, JWM Bulte… - Journal of …, 1998 - Wiley Online Library
MION‐46L, a superparamagnetic iron oxide contrast agent, was investigated for its ability to
increase the sensitivity of in vivo 3D MRI in the detection of brain lesions in a chronic …

Magnetic resonance imaging changes with recombinant human interferon-beta-1a: a short term study in relapsing-remitting multiple sclerosis.

C Pozzilli, S Bastianello, T Koudriavtseva… - Journal of Neurology …, 1996 - jnnp.bmj.com
OBJECTIVE: To evaluate whether recombinant human interferon-beta-1a significantly
affects disease activity as measured by a reduction in the number and volume of Gd …

In vivo MRI and its histological correlates in acute adoptive transfer experimental allergic encephalomyelitis: Quantification of inflammation and oedema

SP Morrissey, H Stodal, U Zettl, C Simonis, S Jung… - Brain, 1996 - academic.oup.com
In vivo proton MRI was carried out on a 7 Tesla system at 2–3 day intervals over 10 days in
rats with adoptive transfer experimental allergic encephalomyelitis (AT-EAE), an animal …

Multiple sclerosis: prospective analysis of TNF-α and 55 kDa TNF receptor in CSF and serum in correlation with clinical and MRI activity

S Spuler, T Yousry, A Scheller, R Voltz, E Holler… - Journal of …, 1996 - Elsevier
The possibility of antagonizing tumor necrosis factor-α (TNF-α) in vivo with antibodies or
soluble TNF receptor has focused much interest on the role of this cytokine in the natural …

Beyond blood brain barrier breakdown – in vivodetection of occult neuroinflammatory foci by magnetic nanoparticles in high field MRI

E Tysiak, P Asbach, O Aktas, H Waiczies… - Journal of …, 2009 - Springer
Abstract Background Gadopentate dimeglumine (Gd-DTPA) enhanced magnetic resonance
imaging (MRI) is widely applied for the visualization of blood brain barrier (BBB) breakdown …

A preliminary study into the sensitivity of disease activity detection by serial weekly magnetic resonance imaging in multiple sclerosis.

M Lai, T Hodgson, M Gawne-Cain, S Webb… - Journal of Neurology …, 1996 - jnnp.bmj.com
Long TR and gadolinium enhanced spin echo brain MRI was performed weekly for three
months in three patients with relapsing-remitting or secondary progressive multiple …